Uncomplicated obesity is associated with abnormal aortic function assessed by cardiovascular magnetic resonance
© Robinson et al; licensee BioMed Central Ltd. 2008
Received: 25 January 2008
Accepted: 13 February 2008
Published: 13 February 2008
Obese subjects with insulin resistance and hypertension have abnormal aortic elastic function, which may predispose them to the development of left ventricular dysfunction. We hypothesised that obesity, uncomplicated by other cardiovascular risk factors, is independently associated with aortic function.
Methods and results
We used magnetic resonance imaging to measure aortic compliance, distensibility and stiffness index in 27 obese subjects (BMI 33 kg/m2) without insulin resistance and with normal cholesterol and blood pressure, and 12 controls (BMI 23 kg/m2). Obesity was associated with reduced aortic compliance (0.9 ± 0.1 vs. 1.5 ± 0.2 mm2/mmHg in controls, p < 0.02) and distensibility (3.3 ± 0.01 vs. 5.6 ± 0.01 mmHg-1 × 10-3, p < 0.02), as well as higher stiffness index (3.4 ± 0.3 vs. 2.1 ± 0.1, p < 0.02). Body mass index and fat mass were negatively correlated with aortic function. Leptin was higher in obesity (8.9 ± 0.6 vs. 4.7 ± 0.6 ng/ml, p < 0.001) and also correlated with aortic measures. In multiple regression models, fat mass, leptin and body mass index were independent predictors of aortic function.
Aortic elastic function is abnormal in obese subjects without other cardiovascular risk factors. These findings highlight the independent importance of obesity in the development of cardiovascular disease.
Obesity affects approximately 300 million people worldwide, and another 750 million are believed to be overweight , representing one of the largest health care challenges of our time. Obesity is associated with high levels of adiposity, significantly increased levels of adipokines such as leptin  and elevated levels of the inflammatory marker C-reactive protein (CRP) . Landmark studies have linked obesity with a higher risk of developing heart failure .
Subjects with obesity have altered aortic function [3, 5, 6]. Physiologically, the aorta maintains low left ventricular after-load, promotes optimal sub-endocardial coronary blood flow , and transforms pulsatile into more laminar blood flow. Increased aortic stiffness leads to higher left ventricular systolic pressures, diminished sub-endocardial blood supply  and may ultimately contribute to left ventricular dysfunction [8, 9]. These changes in arterial mechanics are also associated with coronary artery disease , hypertension [11, 12], diabetes [13, 14], and hypercholesterolaemia [15–17]; disorders which themselves are more common in obesity Therefore, it has been difficult to determine the independent effect of obesity on vascular function.
In this study, we employed the unique features of cardiovascular magnetic resonance imaging – direct visualisation of cardiac and aortic mechanics, with high temporal and spatial resolution, even in subjects with large subcutaneous thoracic fat deposits [18, 19] – to test the hypothesis that obesity is independently associated with abnormal aortic function, in adults without confounding factors such as diabetes, insulin resistance, hypertension, or coronary artery disease.
Control and obese subjects were recruited from the general population of Oxfordshire via newspaper advertisements. The study was approved by the local ethics committee, and subjects gave their informed consent prior to participation.
Participants had fasting venous blood samples collected to assess hepatic and renal function, full blood count, lipid profile, insulin, glucose, C reactive protein (CRP) and leptin. Lipid profile was based on total cholesterol, high density lipoproteins (HDL), triglycerides and a calculated low density lipoprotein (LDL) level . Leptin (LINCO Research Inc., St. Charles Missouri) and C reactive protein (CRP) (MP Biomedicals, Orangeburg, NY) were measured using commercially available ELISA techniques.
To investigate the independent effect of obesity on aortic function, we excluded patients with cardiovascular risk factors or factors that might contribute to sub-optimal vascular function. Hypertensives were identified and excluded based on the Joint National Council on Prevention, Detection, Evaluation and Treatment of High Blood Pressure definitions . Diabetics were identified from medical history or fasting venous blood glucose level ≥ 6.7 mmol/L . Furthermore, the homeostasis insulin model assessment (HOMA) formula was used to calculate an insulin resistance (IR) score . Men with an IR score of > 2.35 and women with a score > 1.88 were excluded based on the European Group for the study of Insulin Resistance (EGIR) guidelines . Smokers, subjects with a history of cerebrovascular or coronary artery disease, those with total blood cholesterol levels > 6 mmol/L and those with abnormal renal, hepatic or haematological function were not included. Additionally, those with contraindications to CMR were not recruited.
Assessment of body size
All participants were weighed on an electronic Seca scale and height was measured on an adjustable Seca standing stadiometer. These measures were used to calculate body mass index. Waist and hip circumferences were measured using a tape measure. Bioelectric impedance using the Bodystat® 1500 was used to assess fat mass.
Cardiovascular magnetic resonance imaging
Aortic cross-sections were manually contoured using CMR Tools® (Imperial College, London, UK). Vascular compliance, distensibility and stiffness index were calculated as described previously . Aortic compliance is the absolute change in area per unit of pressure whereas distensibility is the relative change per unit pressure. Stiffness index examines the logarithmic relationship between pressure and the relative change in aortic cross-sectional area. This takes into account the variation in background arterial distending pressure. Mean aortic compliance, distensibility and stiffness index were calculated by averaging the regional measures. Left ventricular volumes and mass were obtained from the short axis stack by manually contouring end-diastolic and end-systolic endocardial and epicardial borders from base to apex, using Siemens analytical software (ARGUS©). Left ventricular end-diastolic volume (EDV), end-systolic volume (ESV), left ventricular mass (LVM), ejection fraction (EF), stroke volume (SV) and cardiac output (CO) were calculated and, where appropriate, normalised for body size.
Statistical analysis was carried out using SPSS 11.0. Arterial compliance, distensibility, stiffness index and myocardial mass were not normally distributed and were investigated using non-parametric Mann-Whitney test and Spearman's analysis for correlation. All values are reported as mean ± the standard error of the mean (SEM) and a p value of < 0.05 was considered significant. Multiple linear regression was carried out correcting for gender and height to determine predictors of aortic function.
Demographic data-obese and control group
53 ± 10
49 ± 11
75.0 ± 12.6
98.3 ± 19.7†
1.8 ± 0.01
1.70 ± 0.01*
23.9 ± 2.7
33.8 ± 3.0†
Fat Mass (kg)
20.2 ± 6.8
38.3 ± 11.9†
Lean Mass (kg)
54.0 ± 14.9
57.6 ± 14.5
86 ± 8
113 ± 15 *
0.9 ± 0.01
1.0 ± 0.01
127 ± 10
130 ± 9
76 ± 9
80 ± 8
Blood parameters (Table 2)
Biochemical assays-obese and control groups
Total Cholesterol (mmol/L)
4.94 ± 0.12
4.93 ± 0.15
HDL Cholesterol (mmol/L)
1.53 ± 0.1
1.17 ± 0.05*
LDL Cholesterol (mmol/L)
2.95 ± 0.20
3.09 ± 0.21
1.00 ± 0.11
1.31 ± 0.12*
Fasting Glucose (mmol/L)
5.07 ± 0.09
5.0 ± 0.11
2.91 ± 0.33
4.69 ± 0.56*
0.61 ± 0.09
0.65 ± 0.12
4.69 ± 0.57
8.98 ± 0.58†
3.47 ± 0.47
5.26 ± 0.56
There was no significant difference in total or LDL cholesterol levels between groups. Triglyceride levels were 31% higher in the obese (p < 0.05) and HDL levels 13% lower (p < 0.05). Leptin levels were 91% higher in the obese (p < 0.01) whereas CRP levels were not significantly different. Fasting glucose levels were similar between groups. Insulin levels were higher in the obese, but HOMA insulin resistance scores did not vary. BMI correlated positively with leptin (r = 0.8, p < 0.001) and CRP (r = 0.6, p < 0.001) and negatively with HDL (r = -0.7, p < 0.001). Fat mass showed positive correlations with leptin (r = 0.8, p < 0.001) and CRP (r = 0.5, p = 0.001), and negative correlation with HDL cholesterol (r = -0.5, p < 0.001).
Left ventricular function
Left ventricular function-obese and control groups
65 ± 2
63 ± 3
ESV index (ml/m)
28 ± 2
26 ± 1
EDV index (ml/m)
81 ± 5
70 ± 3
SV index (ml/m)
53 ± 4
45 ± 3
LVM index (g/m)
81 ± 6
87 ± 4
Aortic function and obesity (Table 4)
Regional aortic elastic function – obese and control groups
AAO Compliance (mm2/mmHg)
2.04 ± 0.23
1.69 ± 0.26
AAO Distensibility (mmHg-1 × 10-3)
3.60 ± 0.44
3.30 ± 0.63
AAO Stiffness index
2.33 ± 0.1
2.55 ± 0.2
DAOP Compliance (mm2/mmHg)
1.40 ± 0.17
0.83 ± 0.15*
DAOP Distensibility (mmHg-1 × 10-3)
5.00 ± 0.7
3.20 ± 0.5†
DAOP Stiffness index
2.06 ± 0.1
2.89 ± 0.3
DAOD Compliance (mm2/mmHg)
0.93 ± 0.18
0.56 ± 0.12‡
DAOD Distensibility (mmHg-1 × 10-3)
8.10 ± 0.3
3.60 ± 0.7*
DAOD Stiffness index
1.89 ± 0.3
4.00 ± 0.6‡
Obesity was associated with a significant reduction in compliance in the proximal descending thoracic aorta and the distal descending abdominal aorta (Figure 1). Furthermore, there was a corresponding decrease in distensibility of the proximal descending aorta and distal descending aorta. Stiffness index (β) was significantly higher in the obese at the level of the distal descending aorta only. There was no significant difference between groups in aortic compliance, distensibility or stiffness index in the ascending aorta.
There was also a negative correlation noted between waist circumference and aortic compliance (r = -0.53, p = 0.001) and distensibility (r = -0.56, p = <0.001). There were no significant correlations between waist-hip ratios and measures of aortic compliance (r = -0.06, p = 0.75) or distensibility (r = -0.06, p = 0.75).
Determinants of aortic function
Using independent multiple linear regression analysis, a significant negative linear relationship was found between aortic compliance and leptin (Regression Coefficient (RC) = -0.017, 95% Confidence Intervals (CI) = -0.027 to -0.007 p = 0.002), fat mass (RC = -0.029, 95% CI = -0.042 to -0.015, p < 0.001), and BMI (RC = -0.045, 95%CI = -0.70 to -0.020, p = 0.001). On the basis of adjusted r square analysis, fat mass emerged as the strongest predictor of aortic compliance. A significant positive association was noted between aortic compliance and HDL cholesterol (RC = 0.873, 95%CI = 0.278 to 1.468, p = 0.006). Distensibility was similarly determined by fat mass (RC = -0.041, 95%CI = -0.057 to -0.026, p < 0.001), BMI (RC = -0.060, 95%CI = -0.09 to -0.03, p < 0.001) and leptin (RC = -0.019 × 10-2, 95%CI = -0.32 to -0.005, p = 0.008). HDL (RC = 1.309, 95%CI = 0.596 to 2.020, p = 0.001) was positively associated with distensibility. There was no significant relationship demonstrated between CRP, insulin or insulin resistance and aortic function. Thus, fat mass, leptin and BMI emerged as the main predictors of abnormal aortic function in this population.
In this study, cardiovascular magnetic resonance imaging revealed significant changes in aortic mechanical function in an obese population without hypertension, diabetes, insulin resistance or hypercholesterolaemia. The descending aorta had significantly lower compliance, distensibility and a higher stiffness index – all indicators of decreased mechanical and intrinsic elastic function. This functional abnormality strongly correlated with BMI, fat mass, leptin, waist circumference and HDL levels. Even after adjustment for the potential confounders of gender and height, fat mass emerged as the strongest predictor of decreased aortic elasticity, closely followed by leptin, BMI and HDL.
Previous studies of obesity have been largely limited to peripheral vessels, and usually examined obese cohorts with concomitant insulin resistance [26, 27], diabetes [27–29], hypercholesterolaemia  and hypertension [30, 31]. Furthermore, conflicting results on the relationship between increasing BMI, adiposity and vascular stiffness have been published. Oren et al  reported increased aortic compliance in obese subjects compared with lean controls and Raison et al  demonstrated reduced vascular peripheral resistance in obesity. More recent studies have evaluated arterial distensibility in peripheral vessels  and pulse wave velocities  and suggest a negative correlation between fat mass and aortic compliance, more consistent with an adverse impact of obesity on the vasculature.
Oren et al used diastolic blood pressure decay and pulse pressure relative to stroke volume as surrogate measures of compliance of the whole aorta. These were measured by placing a pressure catheter in the ascending aorta. Magnetic resonance imaging has the advantage of studying changes in aortic compliance in different segments of the aorta. Using CMR, Danias et al  studied the ascending aorta in an obese population with cardiac risk factors and reported no difference in compliance compared to controls. However, they did find a reduction in elasticity of the abdominal aorta. They hypothesised that the changes may have been due to physical compression by abdominal fat or structural changes in the vessel wall. As the study included subjects with cardiac risk factors these may also have independently influenced vascular function. Our study demonstrates that changes in distensibility occur in the descending thoracic aorta as well as the abdominal aorta and are independent of abdominal size. These findings suggest the changes in aortic function are less likely to be due to physical compression from abdominal fat. Furthermore, our cohort did not have cardiac risk factors, which suggests obesity has an independent impact on vascular function.
Similar to Danias et al  we found no change in function in the proximal aorta. The precise reason for the proximal sparing of the vessel remains unclear. It is possible that aortic dysfunction in obesity begins distally with an ascending pattern of progression. The aorta is a physiologically heterogeneous vessel with elastin:collagen ratios decreasing distally along its length. Regions with higher proportions of elastin have physiologically greater abilities to stretch and recoil. Impairment of vascular elasticity might commence in vessel sections physiologically less compliant , and this might then affect the entire arterial tree if obesity is sustained.
Although we excluded all subjects with raised glucose or insulin resistance, our population was hyperinsulinaemic. In work done by Ferrannini et al , it was recognised that although insulin hypersecretion can occur in adults with uncomplicated obesity, the prevalence of insulin resistance is low. Further, it was suggested that in the obese with no evidence of insulin resistance, the risk for the development of cardiovascular disease might differ from that seen in the insulin resistant patient. Additionally work done during the San Antonio Heart Study  demonstrated that during an eight year prospective trial, subjects with high HOMA scores (i.e. with evidence of insulin resistance) were the ones at highest risk for cardiovascular events.
The reduced aortic compliance and distensibility seen in individuals with uncomplicated obesity was unrelated to the inflammatory status, as CRP was not correlated to aortic function. Anthropometric parameters and leptin were the strongest predictors of aortic function and therefore may be more important in the pathogenesis of early aortic disease. Elevated leptin has been shown to increase atherosclerotic risk [37, 38]. Knudson et al  demonstrated the presence of leptin receptors on coronary artery endothelium and that through increased endothelial oxidative stress hyperleptinaemia resulted in significant arterial endothelial dysfunction. Additionally, Zarkesh-Esfanai et al  have demonstrated that high leptin levels may lead to the activation of tumour necrosis factor alpha (TNFα). TNFα has been shown to decrease eNOS production and consequently increase vascular tone . We have not measured TNFα but it is conceivable that chronically elevated leptin levels indirectly impair vascular elastic function via TNFα.
Abnormal aortic function is an independent predictor of the development of coronary artery disease and stroke , as well as left ventricular dysfunction. Interestingly, cardiac changes are not yet evident in our cohort with obesity despite a mean age of forty nine. The development of cardiac dysfunction may have been delayed by the absence of other risk factors or the selection of subjects with uncomplicated obesity has identified a specific group with adaptive processes that compensate for changes in aortic function. It would be of interest to determine whether cardiovascular disease and risk factors in obese individuals predisposes them to further decline in aortic function and determine how aortic dysfunction progresses over time in uncomplicated obesity.
Our study is limited by a relatively small sample size and these findings need to be investigated further in larger cohorts with uncomplicated obesity. The lack of variation in left ventricular function between the obese and lean subjects has been demonstrated in other studies . However, with larger sample numbers to facilitate gender and obesity subgroup analysis on the basis of increasing BMI, a pattern towards worsening left ventricular function might have been noted. As changes in aortic distensibility are seen so early, it is possible that genetic factors are relevant to changes in aortic distensibility in obesity. Data on family history of cardiovascular disease was not available in our cohort and more detailed work will be required to investigate the possible contribution of inherited factors. Fat mass distribution is of interest to risk of cardiovascular disease  and can be assessed with magnetic resonance imaging. Future magnetic resonance research could incorporate these measures to determine how adiposity distribution contributes to changes in aortic function. This research could also study other indices of aortic function such as pulse wave velocity and more refined assessments of blood pressure, including use of central aortic pressure. As leptin is produced predominantly in adipocytes, a reduction in fat mass, rather than absolute weight reduction, might be more efficacious in restoring normal aortic function in this group of patients.
CMR is an excellent imaging modality for non-invasive quantitative assessment of vascular mechanics in a clinical study setting, but might prove impractical for screening for increased aortic stiffness in the general obese population. Our study suggests fat mass and BMI have a predictive potential for central arterial dysfunction. Unlike HDL and leptin measurements, which, though predictive, necessitate venepuncture and laboratory testing, BMI and fat mass are both easily measured with scales, callipers or bioelectric impedance. Earlier appreciation of the vascular risk posed by uncomplicated obesity encourages earlier and more aggressive treatment, thus reducing the morbidity and mortality associated with excess body weights.
The authors gratefully acknowledge the vital contribution of their late co-author Dr. Wiesmann, who was seminal in establishing vascular MRI at our centre. We wish to thank Ms Presanis for statistical advice, Miss Watson for technical assistance and Dr. Robson and Mrs Francis for assistance in developing CMR protocols. Dr. Robinson was supported by the Rhodes trust, Dr. Wiesmann by the Wellcome Trust and Deutsche Forschungsgemeinschaft. The British Heart Foundation supported Drs. Scheuermann-Freestone and Leeson, and Professors Channon, Clarke and Neubauer.
- WHO: Obesity: Preventing and Managing the global epidemic. Report of a World Health Organisation consultation on obesity, Geneva. 1998Google Scholar
- Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF: Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996, 334 (5): 292-295. 10.1056/NEJM199602013340503.View ArticlePubMedGoogle Scholar
- Singhal A, Farooqi IS, Cole TJ, O'Rahilly S, Fewtrell M, Kattenhorn M, Lucas A, Deanfield J: Influence of leptin on arterial distensibility: a novel link between obesity and cardiovascular disease?. Circulation. 2002, 106 (15): 1919-1924. 10.1161/01.CIR.0000033219.24717.52.View ArticlePubMedGoogle Scholar
- Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, Kannel WB, Vasan RS: Obesity and the risk of heart failure. N Engl J Med. 2002, 347 (5): 305-313. 10.1056/NEJMoa020245.View ArticlePubMedGoogle Scholar
- Danias PG, Tritos NA, Stuber M, Botnar RM, Kissinger KV, Manning WJ: Comparison of aortic elasticity determined by cardiovascular magnetic resonance imaging in obese versus lean adults. Am J Cardiol. 2003, 91 (2): 195-199. 10.1016/S0002-9149(02)03109-0.View ArticlePubMedGoogle Scholar
- Hubert HB, Feinleib M, McNamara PM, Castelli WP: Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983, 67 (5): 968-977.View ArticlePubMedGoogle Scholar
- Belz GG: Elastic properties and Windkessel function of the human aorta. Cardiovasc Drugs Ther. 1995, 9 (1): 73-83. 10.1007/BF00877747.View ArticlePubMedGoogle Scholar
- Kelly RP, Tunin R, Kass DA: Effect of reduced aortic compliance on cardiac efficiency and contractile function of in situ canine left ventricle. Circ Res. 1992, 71 (3): 490-502.View ArticlePubMedGoogle Scholar
- Ohtsuka S, Kakihana M, Watanabe H, Sugishita Y: Chronically decreased aortic distensibility causes deterioration of coronary perfusion during increased left ventricular contraction. J Am Coll Cardiol. 1994, 24 (5): 1406-1414.View ArticlePubMedGoogle Scholar
- Bogren HG, Mohiaddin RH, Klipstein RK, Firmin DN, Underwood RS, Rees SR, Longmore DB: The function of the aorta in ischemic heart disease: a magnetic resonance and angiographic study of aortic compliance and blood flow patterns. Am Heart J. 1989, 118 (2): 234-247. 10.1016/0002-8703(89)90181-6.View ArticlePubMedGoogle Scholar
- Laurent S, Caviezel B, Beck L, Girerd X, Billaud E, Boutouyrie P, Hoeks A, Safar M: Carotid artery distensibility and distending pressure in hypertensive humans. Hypertension. 1994, 23 (6 Pt 2): 878-883.View ArticlePubMedGoogle Scholar
- Laurent S, Lacolley P, Girerd X, Caviezel B, Beck L, Challande P, Safar M: [Arterial compliance is not diminished in hypertensive patients when compared at the same level of blood pressure]. Arch Mal Coeur Vaiss. 1994, 87 (8): 1069-1072.PubMedGoogle Scholar
- Lehmann ED, Gosling RG, Sonksen PH: Arterial wall compliance in diabetes. Diabet Med. 1992, 9 (2): 114-119.View ArticlePubMedGoogle Scholar
- Eren M, Gorgulu S, Uslu N, Celik S, Dagdeviren B, Tezel T: Relation between aortic stiffness and left ventricular diastolic function in patients with hypertension, diabetes, or both. Heart. 2004, 90 (1): 37-43. 10.1136/heart.90.1.37.PubMed CentralView ArticlePubMedGoogle Scholar
- Lehmann ED, Watts GF, Fatemi-Langroudi B, Gosling RG: Aortic compliance in young patients with heterozygous familial hypercholesterolaemia. Clin Sci (Lond). 1992, 83 (6): 717-721.View ArticleGoogle Scholar
- Lehmann ED, Watts GF, Gosling RG: Aortic distensibility and hypercholesterolaemia. Lancet. 1992, 340 (8828): 1171-1172. 10.1016/0140-6736(92)93210-E.View ArticlePubMedGoogle Scholar
- Dart AM, Lacombe F, Yeoh JK, Cameron JD, Jennings GL, Laufer E, Esmore DS: Aortic distensibility in patients with isolated hypercholesterolaemia, coronary artery disease, or cardiac transplant. Lancet. 1991, 338 (8762): 270-273. 10.1016/0140-6736(91)90415-L.View ArticlePubMedGoogle Scholar
- Oliver JJ, Webb DJ: Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vasc Biol. 2003, 23 (4): 554-566. 10.1161/01.ATV.0000060460.52916.D6.View ArticlePubMedGoogle Scholar
- Hoeks AP, Brands PJ, Smeets FA, Reneman RS: Assessment of the distensibility of superficial arteries. Ultrasound Med Biol. 1990, 16 (2): 121-128. 10.1016/0301-5629(90)90139-4.View ArticlePubMedGoogle Scholar
- Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972, 18 (6): 499-502.PubMedGoogle Scholar
- Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. Jama. 2003, 289 (19): 2560-2572. 10.1001/jama.289.19.2560.View ArticlePubMedGoogle Scholar
- WHO: Diabetes mellitus:report of a WHO study group. Technical report Series No.727. 1985Google Scholar
- Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985, 28 (7): 412-419. 10.1007/BF00280883.View ArticlePubMedGoogle Scholar
- Balkau B, Charles MA: Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med. 1999, 16 (5): 442-443. 10.1046/j.1464-5491.1999.00059.x.View ArticlePubMedGoogle Scholar
- Wiesmann F, Petersen SE, Leeson PM, Francis JM, Robson MD, Wang Q, Choudhury R, Channon KM, Neubauer S: Global impairment of brachial, carotid, and aortic vascular function in young smokers: direct quantification by high-resolution magnetic resonance imaging. J Am Coll Cardiol. 2004, 44 (10): 2056-2064. 10.1016/j.jacc.2004.08.033.View ArticlePubMedGoogle Scholar
- de Simone G, Devereux RB, Palmieri V, Roman MJ, Celentano A, Welty TK, Fabsitz RR, Contaldo F, Howard BV: Relation of insulin resistance to markers of preclinical cardiovascular disease: the Strong Heart Study. Nutr Metab Cardiovasc Dis. 2003, 13 (3): 140-147. 10.1016/S0939-4753(03)80173-4.View ArticlePubMedGoogle Scholar
- Stepp DW, Pollock DM, Frisbee JC: Low-flow vascular remodeling in the metabolic syndrome X. Am J Physiol Heart Circ Physiol. 2004, 286 (3): H964-70. 10.1152/ajpheart.00836.2003.View ArticlePubMedGoogle Scholar
- Willens HJ, Davis W, Herrington DM, Wade K, Kesler K, Mallon S, Brown WV, Reiber JH, Raines JK: Relationship of peripheral arterial compliance and standard cardiovascular risk factors. Vasc Endovascular Surg. 2003, 37 (3): 197-206. 10.1177/153857440303700307.View ArticlePubMedGoogle Scholar
- Salomaa V, Riley W, Kark JD, Nardo C, Folsom AR: Non-insulin-dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness indexes. The ARIC Study. Atherosclerosis Risk in Communities Study. Circulation. 1995, 91 (5): 1432-1443.View ArticlePubMedGoogle Scholar
- Oren S, Grossman E, Frohlich ED: Arterial and venous compliance in obese and nonobese subjects. Am J Cardiol. 1996, 77 (8): 665-667. 10.1016/S0002-9149(97)89331-9.View ArticlePubMedGoogle Scholar
- Dzau VJ, Safar ME: Large conduit arteries in hypertension: role of the vascular renin-angiotensin system. Circulation. 1988, 77 (5): 947-954.View ArticlePubMedGoogle Scholar
- Raison JM, Safar ME, Cambien FA, London GM: Forearm haemodynamics in obese normotensive and hypertensive subjects. J Hypertens. 1988, 6 (4): 299-303. 10.1097/00004872-198804000-00006.View ArticlePubMedGoogle Scholar
- Wildman RP, Mackey RH, Bostom A, Thompson T, Sutton-Tyrrell K: Measures of obesity are associated with vascular stiffness in young and older adults. Hypertension. 2003, 42 (4): 468-473. 10.1161/01.HYP.0000090360.78539.CD.View ArticlePubMedGoogle Scholar
- Mohiaddin RH, Underwood SR, Bogren HG, Firmin DN, Klipstein RH, Rees RS, Longmore DB: Regional aortic compliance studied by magnetic resonance imaging: the effects of age, training, and coronary artery disease. Br Heart J. 1989, 62 (2): 90-96. 10.1136/hrt.62.2.90.PubMed CentralView ArticlePubMedGoogle Scholar
- Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G: Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). J Clin Invest. 1997, 100 (5): 1166-1173. 10.1172/JCI119628.PubMed CentralView ArticlePubMedGoogle Scholar
- Hanley AJ, Williams K, Stern MP, Haffner SM: Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study. Diabetes care. 2002, 25 (7): 1177-1184. 10.2337/diacare.25.7.1177.View ArticlePubMedGoogle Scholar
- Schafer K, Halle M, Goeschen C, Dellas C, Pynn M, Loskutoff DJ, Konstantinides S: Leptin promotes vascular remodeling and neointimal growth in mice. Arterioscler Thromb Vasc Biol. 2004, 24 (1): 112-117. 10.1161/01.ATV.0000105904.02142.e7.View ArticlePubMedGoogle Scholar
- Peelman F, Waelput W, Iserentant H, Lavens D, Eyckerman S, Zabeau L, Tavernier J: Leptin: linking adipocyte metabolism with cardiovascular and autoimmune diseases. Prog Lipid Res. 2004, 43 (4): 283-301. 10.1016/j.plipres.2004.03.001.View ArticlePubMedGoogle Scholar
- Knudson JD, Dincer UD, Zhang C, Swafford AN, Koshida R, Picchi A, Focardi M, Dick GM, Tune JD: Leptin receptors are expressed in coronary arteries, and hyperleptinemia causes significant coronary endothelial dysfunction. Am J Physiol Heart Circ Physiol. 2005, 289 (1): H48-56. 10.1152/ajpheart.01159.2004.View ArticlePubMedGoogle Scholar
- Zarkesh-Esfahani H, Pockley G, Metcalfe RA, Bidlingmaier M, Wu Z, Ajami A, Weetman AP, Strasburger CJ, Ross RJ: High-dose leptin activates human leukocytes via receptor expression on monocytes. J Immunol. 2001, 167 (8): 4593-4599.View ArticlePubMedGoogle Scholar
- Alonso J, Sanchez de Miguel L, Monton M, Casado S, Lopez-Farre A: Endothelial cytosolic proteins bind to the 3' untranslated region of endothelial nitric oxide synthase mRNA: regulation by tumor necrosis factor alpha. Mol Cell Biol. 1997, 17 (10): 5719-5726.PubMed CentralView ArticlePubMedGoogle Scholar
- Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML, Schalekamp MA, Asmar R, Reneman RS, Hoeks AP, Breteler MM, Witteman JC: Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation. 2006, 113 (5): 657-663. 10.1161/CIRCULATIONAHA.105.555235.View ArticlePubMedGoogle Scholar
- Otto ME, Belohlavek M, Khandheria B, Gilman G, Svatikova A, Somers V: Comparison of right and left ventricular function in obese and nonobese men. Am J Cardiol. 2004, 93 (12): 1569-1572. 10.1016/j.amjcard.2004.02.073.View ArticlePubMedGoogle Scholar
- Campos H, Bailey SM, Gussak LS, Siles X, Ordovas JM, Schaefer EJ: Relations of body habitus, fitness level, and cardiovascular risk factors including lipoproteins and apolipoproteins in a rural and urban Costa Rican population. Arterioscler Thromb. 1991, 11 (4): 1077-1088.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.